You are here: Industry Insights > gene

News List

Cell and Gene Therapy Manufacturing: Operational Challenges and Strategic Considerations Neeta Ratanghayra
December 20, 2024
Producing CGTs requires highly specialized infrastructure, precise processes, and significant investments, making the manufacturing landscape both complex and costly.
Making Cell and Gene Therapy Affordable Suzanne Elvidge
November 04, 2024
Cell and gene therapies (CGTs) have revolutionised medicine, providing personalised and targeted treatment for life-limiting diseases from genetic disorders to hard-to-treat cance.However, these cutting-edge therapeutics can come with a high price tag.
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test Pharmasources
February 24, 2023
Group in strategic collaboration with Divine Genes to offer genetic tests related to reproductive health in Malaysia and overseas.
MGI Tech's Innovative Sequencing Technology Drives Mangrove Conservation Efforts in Thailand PR Newswire
December 09, 2024
MGI Tech Co., Ltd. has partnered with National Omics Center (NOC) under the National Science and Technology Development Agency (NSTDA) to leverage advanced sequencing technology for mangrove conservation research.
Metagenomi raises $175m in Series B round to develop treatment pipeline Pharmaceutical-Technology
January 28, 2022
With the latest funding round, the genetic medicines company has raised a total of $300m.
TrakCel, Körber Partner to Advance Manufacturing of C&G Therapies contractpharma
January 25, 2022
Integration of OCELLOS and PAS-X will allow cell and gene therapy customers to effectively share data detailing manufacturing events.
Catalent Increases Specialized Packaging Capabilities contractpharma
January 11, 2022
Expands Philadelphia facility to support growing biologic and cell and gene therapy markets.
Astellas and Dyno Therapeutics to Collaborate on Research to Develop Next-Gen AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle AmericanPharmaceuticalReview
December 03, 2021
Astellas Pharma Inc. announced an option and license agreement was signed on November 23 to develop next-generation adeno-associated virus (AAV) vectors for gene therapy directed to skeletal and cardiac muscle using Dyno's CapsidMap™ platform.
DECODR app identifies unintentional DNA mutations from CRISPR gene therapies europeanpharmaceuticalreview
February 24, 2021
The DECODR app was developed to accelerate the development of CRISPR gene therapies, producing similar data as deep sequencing processes in a shorter timeframe and at less cost.
Scientists find five key genes are linked to severe COVID-19 expresspharma
December 14, 2020
The genes - called IFNAR2, TYK2, OAS1, DPP9 and CCR2 – partially explain why some people become desperately sick with COVID-19.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page